Page last updated: 2024-09-03

cimadronate and Peritoneal Carcinomatosis

cimadronate has been researched along with Peritoneal Carcinomatosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Iguchi, H; Ikeda, M; Inoue, K; Kataoka, Y; Matsusue, K; Nishino, Y; Nishiyama, K; Takiguchi, S	1

Other Studies

1 other study(ies) available for cimadronate and Peritoneal Carcinomatosis

Article	Year
The bisphosphonate incadronate inhibits intraperitoneal dissemination in an in vivo pancreatic cancer model. Oncology reports, 2012, Volume: 28, Issue:1 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Diphosphonates; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Peritoneal Neoplasms; rho-Associated Kinases; Tumor Burden; Xenograft Model Antitumor Assays	2012

Article

Year

The bisphosphonate incadronate inhibits intraperitoneal dissemination in an in vivo pancreatic cancer model.

Oncology reports, 2012, Volume: 28, Issue:1

Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Diphosphonates; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Peritoneal Neoplasms; rho-Associated Kinases; Tumor Burden; Xenograft Model Antitumor Assays

2012